Overview

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Status:
Active, not recruiting
Trial end date:
2022-04-11
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to understand safety (e.g., occurrence of adverse drug reactions [ADRs]) and efficacy data on the long-term use of Vyndaqel Capsules (hereinafter referred to as Vyndaqel) in all patients who received this drug under actual use conditions after its marketing.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:

The subjects of this surveillance are all patients who received Vyndaqel.

Exclusion Criteria:

Patients not receive Vyndaqel.